Point72 Asia (Singapore) Pte. Ltd. Surmodics Inc Transaction History
Point72 Asia (Singapore) Pte. Ltd.
- $384 Billion
- Q1 2024
A detailed history of Point72 Asia (Singapore) Pte. Ltd. transactions in Surmodics Inc stock. As of the latest transaction made, Point72 Asia (Singapore) Pte. Ltd. holds 980 shares of SRDX stock, worth $41,130. This represents 0.01% of its overall portfolio holdings.
Number of Shares
980
Previous 286
242.66%
Holding current value
$41,130
Previous $10.4 Million
176.44%
% of portfolio
0.01%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SRDX
# of Institutions
110Shares Held
12.6MCall Options Held
200Put Options Held
4.7K-
Trigran Investments, Inc.2.36MShares$99 Million6.71% of portfolio
-
Black Rock Inc. New York, NY1.05MShares$44.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA865KShares$36.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY854KShares$35.8 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT801KShares$33.6 Million1.92% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $588M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...